enGene Holdings's market cap is currently ―. The company's EPS TTM is $-5.148; its P/E ratio is -2.77; enGene Holdings is scheduled to report earnings on March 11, 2024, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.

	Oct 23	Jul 23	Oct 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	-	-	-	$ -523.26K	$ -371.33K
EBITDA	-	-	-	$ -523.26K	$ -371.33K
Net Income Common Stockholders	-	$ -5.99M	-	$ 72.67K	$ -258.28K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 81.52M	$ 37.59M	$ 20.43M	$ 457.00K	$ 774.91K
Total Assets	$ 86.96M	$ 46.28M	$ 23.91M	$ 131.21M	$ 131.06M
Total Debt	$ 562.00K	$ 67.16M	$ 22.46M	$ 0.00	$ 0.00
Net Debt	$ -80.96M	$ 29.57M	$ 2.03M	$ -457.00K	$ -774.91K
Total Liabilities	$ 14.47M	$ 87.08M	$ 47.41M	$ 4.40M	$ 4.33M
Stockholders Equity	$ 72.49M	$ -40.80M	$ -23.50M	$ 126.80M	$ 126.73M
Cash Flow	-
Free Cash Flow	-	-	-	$ -317.92K	$ -134.65K
Operating Cash Flow	-	-	-	$ -317.92K	$ -134.65K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in USD

enGene Holdings Earnings and Revenue History

Income Statement >

enGene Holdings Debt to Assets

Balance Sheet >

enGene Holdings Cash Flow

Cash Flow >

enGene Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing